235 filings
Page 7 of 12
8-K
euc3guj5uyeup0c
4 Mar 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
8-K
vn9etu4yvr1nc74
15 Jan 19
ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders
8:38pm
8-K
nsdnuvd3x56v0kk7
2 Jan 19
Regulation FD Disclosure
4:26pm
8-K
zb21rq5rhk c3s
14 Dec 18
Departure of Directors or Certain Officers
4:30pm
8-K
d6znmswt87s
13 Nov 18
Departure of Directors or Certain Officers
5:00pm
8-K
ifn5ytu 4z
19 Oct 18
Departure of Directors or Certain Officers
4:31pm
8-K
esde25c 709
18 Oct 18
Departure of Directors or Certain Officers
4:31pm
8-K
yp24dzy0pai36s
3 Oct 18
Departure of Directors or Certain Officers
4:31pm
8-K
ja5ju4 opl9nf
18 Sep 18
ContraVir Pharmaceuticals Announces Completion of Phase 1 with CRV431
12:00am
8-K
duk8r8c1
5 Sep 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
txddjm
27 Aug 18
Other Events
12:00am
8-K
q7oh1jckjik77yng0
6 Aug 18
ContraVir Pharmaceuticals Provides an Update to Corporate Objectives
5:27pm
8-K
iv0j1epa
23 Jul 18
ContraVir Pharmaceuticals Reports Progress in Phase 1/2A Trial of CRV431
12:37pm
8-K
2awy8h fejlb
5 Jul 18
Material Modifications to Rights of Security Holders
4:03pm
8-K
wfg8dpf0exr8waipj1
25 Jun 18
Other Events
11:24am
8-K
j1pn84a
21 Jun 18
Other Events
7:58am
8-K
84ozlz0ms llq7a
19 Jun 18
ContraVir Pharmaceuticals to Provide Corporate, Business and Clinical Updates
12:00am
8-K
8reou68z
14 Jun 18
ContraVir Pharmaceuticals Announces the Approval of the IND and Initiation of the Clinical Development Program of CRV431 in the United States
12:00am
8-K
2u5g0ac uy
13 Jun 18
ContraVir Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
12:00am
8-K
o4okfs9 qkqu9r4ccej
6 Jun 18
ContraVir Pharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
6:01am